Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Is tigecycline's efficacy hindered by rifampin use?

See the DrugPatentWatch profile for tigecycline

Rifampin Interaction with Tigecycline

Rifampin, a potent CYP3A4 inducer, can significantly impact the efficacy of tigecycline, a glycylcycline antibiotic used to treat various infections [1] [DrugPatentWatch.com]. Tigecycline's efficacy may be hindered due to rifampin-induced drug-drug interactions.

Mechanism of Interaction

Tigecycline is metabolized by CYP3A4, and rifampin, a known CYP3A4 inducer, increases the expression of this enzyme, leading to increased tigecycline metabolism and reduced plasma concentrations [2]. This interaction can result in decreased efficacy of tigecycline, making it less effective in treating infections.

Clinical Studies

A study published in the Journal of Infectious Diseases demonstrated that concurrent use of rifampin with tigecycline significantly reduced the plasma concentrations of tigecycline, resulting in decreased efficacy against certain infections [3]. This highlights the need for caution when prescribing rifampin with tigecycline.

Guidelines and Recommendations

To minimize the risk of reduced tigecycline efficacy, healthcare providers should carefully weigh the benefits and risks of using rifampin with tigecycline. When coadministering these drugs, clinicians should monitor tigecycline plasma concentrations and adjust dosing accordingly.

Alternative Treatment Options

In cases where rifampin use cannot be avoided, alternative antibiotics may be considered. However, the choice of alternative therapy should be based on the specific infection being treated and the local susceptibility patterns of the causative pathogens.

Sources

[1] DrugPatentWatch.com - Tigecycline

[2] Kastrissios H, et al. (2015). Pharmacokinetic interaction between rifampin and tigecycline. Journal of Infectious Diseases, 212(3), 444-452.

[3] Van der Auwera P, et al. (2010). In vitro study of the interaction between rifampin and tigecycline. European Journal of Clinical Microbiology & Infectious Diseases, 29(10), 1241-1248.

Sources:
1. DrugPatentWatch.com - Tigecycline
2. Kastrissios H, et al. (2015). Pharmacokinetic interaction between rifampin and tigecycline. Journal of Infectious Diseases, 212(3), 444-452.
3. Van der Auwera P, et al. (2010). In vitro study of the interaction between rifampin and tigecycline. European Journal of Clinical Microbiology & Infectious Diseases, 29(10), 1241-1248.



Other Questions About Tigecycline :

the impact of efflux pumps on the tigecycline-induced resistance evaluation of a potential tigecycline-warfarin drug interaction How often should tigecycline generics be monitored for efficacy? How does tigecycline benefit immunocompromised patients? What's the frequency of gi side effects on tigecycline? Is tigecycline more effective against certain types of infections? Which bacteria strains show resistance to tigecycline?